APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Codeine Painkillers

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Codeine Painkillers Market Outlook and Growth Opportunities 2026

Report ID 17397921042 January 2026199 pages

Choose your research edition.

Industry ResearchCodeine Painkillers Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Codeine Painkillers Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Codeine Painkillers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Codeine Painkillers Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Codeine Painkillers Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Codeine Painkillers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Codeine Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Codeine Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Codeine Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Codeine Painkillers market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Codeine Painkillers market include TEVA, Johnson & Johnson, Novartis, Viatris, Taiji, Sanofi Aventis, Pharmaceutical Associates, Medreich and Mallinckrodt, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Codeine Painkillers market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Codeine Painkillers and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Codeine Painkillers revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Codeine Painkillers market.

Codeine Painkillers Segment by Company

TEVA

Johnson & Johnson

Novartis

Viatris

Taiji

Sanofi Aventis

Pharmaceutical Associates

Medreich

Mallinckrodt

Lannett Company

Laboratoire Riva

Hikma

Cipla

Aristo Pharma GmbH

Apotex

Codeine Painkillers Segment by Type

Single-ingredient Codeine

Multi-ingredient Medications Codeine

Codeine Painkillers Segment by Application

Narcotic Analgesic

Antitussive

Others

Codeine Painkillers Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Codeine Painkillers status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Codeine Painkillers key companies, revenue, market share, and recent developments.

3. To split the Codeine Painkillers breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Codeine Painkillers market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Codeine Painkillers significant trends, drivers, influence factors in global and regions.

6. To analyze Codeine Painkillers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Painkillers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Codeine Painkillers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Painkillers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Codeine Painkillers industry.

Chapter 3: Detailed analysis of Codeine Painkillers company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Codeine Painkillers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Codeine Painkillers in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Codeine Painkillers Industry Trends Table 2. Codeine Painkillers Industry Drivers Table 3. Codeine Painkillers Industry Opportunities and Challenges Table 4. Codeine Painkillers Industry Restraints Table 5. Global Codeine Painkillers Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Codeine Painkillers Revenue Share by Company (2021-2026) Table 7. Global Codeine Painkillers Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Codeine Painkillers Key Company Manufacturing Base & Headquarters Table 9. Global Codeine Painkillers Company, Product Type & Application Table 10. Global Codeine Painkillers Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Codeine Painkillers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single-ingredient Codeine Table 15. Significant Companies of Multi-ingredient Medications Codeine Table 16. Global Codeine Painkillers Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Codeine Painkillers Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Codeine Painkillers Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Codeine Painkillers Sales Value Share by Type (2021-2026) Table 20. Global Codeine Painkillers Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Narcotic Analgesic Table 22. Significant Companies of Antitussive Table 23. Significant Companies of Others Table 24. Global Codeine Painkillers Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Codeine Painkillers Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Codeine Painkillers Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Codeine Painkillers Sales Value Share by Application (2021-2026) Table 28. Global Codeine Painkillers Sales Value Share by Application (2027-2032) Table 29. Global Codeine Painkillers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Codeine Painkillers Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Codeine Painkillers Sales Value Share by Region (2021-2026) Table 32. Global Codeine Painkillers Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Codeine Painkillers Sales Value Share by Region (2027-2032) Table 34. Global Codeine Painkillers Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Codeine Painkillers Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Codeine Painkillers Sales Value Market Share by Country (2021-2026) Table 37. Global Codeine Painkillers Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Codeine Painkillers Sales Value Market Share by Country (2027-2032) Table 39. TEVA Company Information Table 40. TEVA Business Overview Table 41. TEVA Codeine Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. TEVA Codeine Painkillers Product Portfolio Table 43. TEVA Recent Development Table 44. Johnson & Johnson Company Information Table 45. Johnson & Johnson Business Overview Table 46. Johnson & Johnson Codeine Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Johnson & Johnson Codeine Painkillers Product Portfolio Table 48. Johnson & Johnson Recent Development Table 49. Novartis Company Information Table 50. Novartis Business Overview Table 51. Novartis Codeine Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Novartis Codeine Painkillers Product Portfolio Table 53. Novartis Recent Development Table 54. Viatris Company Information Table 55. Viatris Business Overview Table 56. Viatris Codeine Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Viatris Codeine Painkillers Product Portfolio Table 58. Viatris Recent Development Table 59. Taiji Company Information Table 60. Taiji Business Overview Table 61. Taiji Codeine Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Taiji Codeine Painkillers Product Portfolio Table 63. Taiji Recent Development Table 64. Sanofi Aventis Company Information Table 65. Sanofi Aventis Business Overview Table 66. Sanofi Aventis Codeine Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sanofi Aventis Codeine Painkillers Product Portfolio Table 68. Sanofi Aventis Recent Development Table 69. Pharmaceutical Associates Company Information Table 70. Pharmaceutical Associates Business Overview Table 71. Pharmaceutical Associates Codeine Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Pharmaceutical Associates Codeine Painkillers Product Portfolio Table 73. Pharmaceutical Associates Recent Development Table 74. Medreich Company Information Table 75. Medreich Business Overview Table 76. Medreich Codeine Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Medreich Codeine Painkillers Product Portfolio Table 78. Medreich Recent Development Table 79. Mallinckrodt Company Information Table 80. Mallinckrodt Business Overview Table 81. Mallinckrodt Codeine Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Mallinckrodt Codeine Painkillers Product Portfolio Table 83. Mallinckrodt Recent Development Table 84. Lannett Company Company Information Table 85. Lannett Company Business Overview Table 86. Lannett Company Codeine Painkillers Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Lannett Company Codeine Painkillers Product Portfolio Table 88. Lannett Company Recent Development Table 89. Laboratoire Riva Company Information Table 90. Laboratoire Riva Business Overview Table 91. Laboratoire Riva Codeine Painkillers Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Laboratoire Riva Codeine Painkillers Product Portfolio Table 93. Laboratoire Riva Recent Development Table 94. Hikma Company Information Table 95. Hikma Business Overview Table 96. Hikma Codeine Painkillers Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hikma Codeine Painkillers Product Portfolio Table 98. Hikma Recent Development Table 99. Cipla Company Information Table 100. Cipla Business Overview Table 101. Cipla Codeine Painkillers Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Cipla Codeine Painkillers Product Portfolio Table 103. Cipla Recent Development Table 104. Aristo Pharma GmbH Company Information Table 105. Aristo Pharma GmbH Business Overview Table 106. Aristo Pharma GmbH Codeine Painkillers Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Aristo Pharma GmbH Codeine Painkillers Product Portfolio Table 108. Aristo Pharma GmbH Recent Development Table 109. Apotex Company Information Table 110. Apotex Business Overview Table 111. Apotex Codeine Painkillers Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Apotex Codeine Painkillers Product Portfolio Table 113. Apotex Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Codeine Painkillers Product Image Figure 2. Global Codeine Painkillers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Codeine Painkillers Market Size (2021-2032) & (US$ Million) Figure 4. Global Codeine Painkillers Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single-ingredient Codeine Image Figure 8. Multi-ingredient Medications Codeine Image Figure 9. Global Codeine Painkillers Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Codeine Painkillers Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Codeine Painkillers Sales Value Share by Type (2021-2032) Figure 12. Narcotic Analgesic Image Figure 13. Antitussive Image Figure 14. Others Image Figure 15. Global Codeine Painkillers Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Codeine Painkillers Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Codeine Painkillers Sales Value Share by Application (2021-2032) Figure 18. Global Codeine Painkillers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Codeine Painkillers Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Codeine Painkillers Sales Value (2021-2032) & (US$ Million) Figure 21. North America Codeine Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Codeine Painkillers Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Codeine Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Codeine Painkillers Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Codeine Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Codeine Painkillers Sales Value (2021-2032) & (US$ Million) Figure 27. South America Codeine Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Codeine Painkillers Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Codeine Painkillers Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Codeine Painkillers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Codeine Painkillers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Codeine Painkillers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Single-ingredient Codeine
  • Multi-ingredient Medications Codeine
Applications
  • Narcotic Analgesic
  • Antitussive
  • Others
Companies covered
  • TEVA
  • Johnson & Johnson
  • Novartis
  • Viatris
  • Taiji
  • Sanofi Aventis
  • Pharmaceutical Associates
  • Medreich
  • Mallinckrodt
  • Lannett Company
  • Laboratoire Riva
  • Hikma
  • Cipla
  • Aristo Pharma GmbH
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Codeine Painkillers Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Codeine Painkillers Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Codeine Painkillers Market Dynamics
  1. 2.1 Codeine Painkillers Industry Trends
  2. 2.2 Codeine Painkillers Industry Drivers
  3. 2.3 Codeine Painkillers Industry Opportunities and Challenges
  4. 2.4 Codeine Painkillers Industry Restraints
3 Codeine Painkillers Market by Company
  1. 3.1 Global Codeine Painkillers Company Revenue Ranking in 2025
  2. 3.2 Global Codeine Painkillers Revenue by Company (2021-2026)
  3. 3.3 Global Codeine Painkillers Company Ranking (2024-2026)
  4. 3.4 Global Codeine Painkillers Company Manufacturing Base and Headquarters
  5. 3.5 Global Codeine Painkillers Company Product Type and Application
  6. 3.6 Global Codeine Painkillers Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Codeine Painkillers Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Codeine Painkillers Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Codeine Painkillers Market by Type
  1. 4.1 Codeine Painkillers Type Introduction
  2. 4.1.1 Single-ingredient Codeine
  3. 4.1.2 Multi-ingredient Medications Codeine
  4. 4.2 Global Codeine Painkillers Sales Value by Type
  5. 4.2.1 Global Codeine Painkillers Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Codeine Painkillers Sales Value by Type (2021-2032)
  7. 4.2.3 Global Codeine Painkillers Sales Value Share by Type (2021-2032)
5 Codeine Painkillers Market by Application
  1. 5.1 Codeine Painkillers Application Introduction
  2. 5.1.1 Narcotic Analgesic
  3. 5.1.2 Antitussive
  4. 5.1.3 Others
  5. 5.2 Global Codeine Painkillers Sales Value by Application
  6. 5.2.1 Global Codeine Painkillers Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Codeine Painkillers Sales Value by Application (2021-2032)
  8. 5.2.3 Global Codeine Painkillers Sales Value Share by Application (2021-2032)
6 Codeine Painkillers Regional Value Analysis
  1. 6.1 Global Codeine Painkillers Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Codeine Painkillers Sales Value by Region (2021-2032)
  3. 6.2.1 Global Codeine Painkillers Sales Value by Region: 2021-2026
  4. 6.2.2 Global Codeine Painkillers Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Codeine Painkillers Sales Value (2021-2032)
  7. 6.3.2 North America Codeine Painkillers Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Codeine Painkillers Sales Value (2021-2032)
  10. 6.4.2 Europe Codeine Painkillers Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Codeine Painkillers Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Codeine Painkillers Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Codeine Painkillers Sales Value (2021-2032)
  16. 6.6.2 South America Codeine Painkillers Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Codeine Painkillers Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Codeine Painkillers Sales Value Share by Country, 2025 VS 2032
7 Codeine Painkillers Country-level Value Analysis
  1. 7.1 Global Codeine Painkillers Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Codeine Painkillers Sales Value by Country (2021-2032)
  3. 7.2.1 Global Codeine Painkillers Sales Value by Country (2021-2026)
  4. 7.2.2 Global Codeine Painkillers Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Codeine Painkillers Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Codeine Painkillers Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Codeine Painkillers Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Codeine Painkillers Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Codeine Painkillers Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Codeine Painkillers Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Codeine Painkillers Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Codeine Painkillers Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Codeine Painkillers Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Codeine Painkillers Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Codeine Painkillers Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Codeine Painkillers Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Codeine Painkillers Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Codeine Painkillers Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Codeine Painkillers Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Codeine Painkillers Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Codeine Painkillers Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Codeine Painkillers Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Codeine Painkillers Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Codeine Painkillers Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Codeine Painkillers Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Codeine Painkillers Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Codeine Painkillers Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Codeine Painkillers Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Codeine Painkillers Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Codeine Painkillers Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Codeine Painkillers Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Codeine Painkillers Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Codeine Painkillers Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Codeine Painkillers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 TEVA
  2. 8.1.1 TEVA Company Information
  3. 8.1.2 TEVA Business Overview
  4. 8.1.3 TEVA Codeine Painkillers Revenue and Gross Margin (2021-2026)
  5. 8.1.4 TEVA Codeine Painkillers Product Portfolio
  6. 8.1.5 TEVA Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Codeine Painkillers Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Codeine Painkillers Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Codeine Painkillers Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Codeine Painkillers Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Viatris
  20. 8.4.1 Viatris Company Information
  21. 8.4.2 Viatris Business Overview
  22. 8.4.3 Viatris Codeine Painkillers Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Viatris Codeine Painkillers Product Portfolio
  24. 8.4.5 Viatris Recent Developments
  25. 8.5 Taiji
  26. 8.5.1 Taiji Company Information
  27. 8.5.2 Taiji Business Overview
  28. 8.5.3 Taiji Codeine Painkillers Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Taiji Codeine Painkillers Product Portfolio
  30. 8.5.5 Taiji Recent Developments
  31. 8.6 Sanofi Aventis
  32. 8.6.1 Sanofi Aventis Company Information
  33. 8.6.2 Sanofi Aventis Business Overview
  34. 8.6.3 Sanofi Aventis Codeine Painkillers Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Aventis Codeine Painkillers Product Portfolio
  36. 8.6.5 Sanofi Aventis Recent Developments
  37. 8.7 Pharmaceutical Associates
  38. 8.7.1 Pharmaceutical Associates Company Information
  39. 8.7.2 Pharmaceutical Associates Business Overview
  40. 8.7.3 Pharmaceutical Associates Codeine Painkillers Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pharmaceutical Associates Codeine Painkillers Product Portfolio
  42. 8.7.5 Pharmaceutical Associates Recent Developments
  43. 8.8 Medreich
  44. 8.8.1 Medreich Company Information
  45. 8.8.2 Medreich Business Overview
  46. 8.8.3 Medreich Codeine Painkillers Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medreich Codeine Painkillers Product Portfolio
  48. 8.8.5 Medreich Recent Developments
  49. 8.9 Mallinckrodt
  50. 8.9.1 Mallinckrodt Company Information
  51. 8.9.2 Mallinckrodt Business Overview
  52. 8.9.3 Mallinckrodt Codeine Painkillers Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mallinckrodt Codeine Painkillers Product Portfolio
  54. 8.9.5 Mallinckrodt Recent Developments
  55. 8.10 Lannett Company
  56. 8.10.1 Lannett Company Company Information
  57. 8.10.2 Lannett Company Business Overview
  58. 8.10.3 Lannett Company Codeine Painkillers Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lannett Company Codeine Painkillers Product Portfolio
  60. 8.10.5 Lannett Company Recent Developments
  61. 8.11 Laboratoire Riva
  62. 8.11.1 Laboratoire Riva Company Information
  63. 8.11.2 Laboratoire Riva Business Overview
  64. 8.11.3 Laboratoire Riva Codeine Painkillers Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Laboratoire Riva Codeine Painkillers Product Portfolio
  66. 8.11.5 Laboratoire Riva Recent Developments
  67. 8.12 Hikma
  68. 8.12.1 Hikma Company Information
  69. 8.12.2 Hikma Business Overview
  70. 8.12.3 Hikma Codeine Painkillers Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hikma Codeine Painkillers Product Portfolio
  72. 8.12.5 Hikma Recent Developments
  73. 8.13 Cipla
  74. 8.13.1 Cipla Company Information
  75. 8.13.2 Cipla Business Overview
  76. 8.13.3 Cipla Codeine Painkillers Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cipla Codeine Painkillers Product Portfolio
  78. 8.13.5 Cipla Recent Developments
  79. 8.14 Aristo Pharma GmbH
  80. 8.14.1 Aristo Pharma GmbH Company Information
  81. 8.14.2 Aristo Pharma GmbH Business Overview
  82. 8.14.3 Aristo Pharma GmbH Codeine Painkillers Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Aristo Pharma GmbH Codeine Painkillers Product Portfolio
  84. 8.14.5 Aristo Pharma GmbH Recent Developments
  85. 8.15 Apotex
  86. 8.15.1 Apotex Company Information
  87. 8.15.2 Apotex Business Overview
  88. 8.15.3 Apotex Codeine Painkillers Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Apotex Codeine Painkillers Product Portfolio
  90. 8.15.5 Apotex Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst